Hainan Shuangcheng Pharmaceuticals Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is 41.94% vs -55.14% in Mar 2026",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is 1,683.33% vs -103.70% in Mar 2026",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'26",
        "Mar'26",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "68.70",
          "val2": "48.40",
          "chgp": "41.94%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "24.60",
          "val2": "16.20",
          "chgp": "51.85%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2.30",
          "val2": "2.30",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.10",
          "val2": "0.10",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "9.50",
          "val2": "-0.60",
          "chgp": "1,683.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "158.10%",
          "val2": "52.40%",
          "chgp": "10.57%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 63.72% vs -28.00% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 108.37% vs -47.64% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "275.70",
          "val2": "168.40",
          "chgp": "63.72%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "72.50",
          "val2": "-16.30",
          "chgp": "544.79%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "9.70",
          "val2": "9.30",
          "chgp": "4.30%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-2.70",
          "val2": "-29.00",
          "chgp": "90.69%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "8.90",
          "val2": "-106.30",
          "chgp": "108.37%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "62.90%",
          "val2": "-426.10%",
          "chgp": "48.90%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ

Jun'26

Mar'26

Change(%)

Net Sales

68.70

48.40

41.94%

Operating Profit (PBDIT) excl Other Income

24.60

16.20

51.85%

Interest

2.30

2.30

Exceptional Items

0.10

0.10

Consolidate Net Profit

9.50

-0.60

1,683.33%

Operating Profit Margin (Excl OI)

158.10%

52.40%

10.57%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Jun 2026 is 41.94% vs -55.14% in Mar 2026

Consolidated Net Profit

QoQ Growth in quarter ended Jun 2026 is 1,683.33% vs -103.70% in Mar 2026

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

275.70

168.40

63.72%

Operating Profit (PBDIT) excl Other Income

72.50

-16.30

544.79%

Interest

9.70

9.30

4.30%

Exceptional Items

-2.70

-29.00

90.69%

Consolidate Net Profit

8.90

-106.30

108.37%

Operating Profit Margin (Excl OI)

62.90%

-426.10%

48.90%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 63.72% vs -28.00% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 108.37% vs -47.64% in Dec 2024

All Annual Results